Taiwan Bio Therapeutics (ROCO:6892) Interest Expense : NT$-5.6 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Taiwan Bio Therapeutics's interest expense for the three months ended in Mar. 2025 was NT$ -1.9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-5.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Taiwan Bio Therapeutics's Operating Income for the three months ended in Mar. 2025 was NT$ -77.0 Mil. Taiwan Bio Therapeutics's Interest Expense for the three months ended in Mar. 2025 was NT$ -1.9 Mil. Taiwan Bio Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Taiwan Bio Therapeutics Interest Expense Historical Data

The historical data trend for Taiwan Bio Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Interest Expense Chart

Taiwan Bio Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.12

-2.86

-5.42

-5.31

-5.21

Taiwan Bio Therapeutics Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial								-1.45	-1.26	-1.24	-1.26	-1.87

Taiwan Bio Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-5.6 Mil.

Taiwan Bio Therapeutics (ROCO:6892) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Taiwan Bio Therapeutics's Interest Expense for the three months ended in Mar. 2025 was NT$-1.9 Mil. Its Operating Income for the three months ended in Mar. 2025 was NT$-77.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was NT$306.4 Mil.

Taiwan Bio Therapeutics's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Taiwan Bio Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Taiwan Bio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744

Website

https://www.twbio-thera.com

Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines